Bone cancer pain (BCP) is a severe type of hyperpathic pain occurring with primary bone tumors or advanced cancers which metastasize to bones. BCP can detrimentally reduce quality of life and presents a challenge to modern medicine. Studies have shown that exogenous H 2 S may act as a neuroprotectant to protect against some diseases in central nervous system. The preset study aimed to investigate the antinociceptive effect of H 2 S in BCP. We first measured the changes of serum H 2 S in patients with BCP and analyzed the relationship between them, then investigated the effect of H 2 S preconditioning on BCP, and explored the mechanism in rat model. Our results revealed that serum H 2 S level was negatively correlated with pain scores. In the rat model of BCP, preconditioning with H 2 S significantly reduced BCP, demonstrated by the decrease of thermal hyperalgesia and mechanical allodynia. The mechanism of H 2 S preconditioning may involve microglia deactivation and inflammation inhibition in the spinal cord, in which the proliferator-activated receptor gamma/p38/Jun N-terminal kinase pathway is activated.
Introduction
BCP is a severe type of hyperpathic pain which can be induced by both primary bone tumor and advanced cancer when it metastasizes to bones. 1 The human skeleton is the most common target of metastatic cancer, which induces neuropathic pain that usually requires radiotherapy, hypercalcemia, or even spinal cord/nerve root compression to get relief. The unique mechanism of BCP makes it resistant to morphine treatment and the most unbearable symptom accompanying primary bone cancers and bone metastases. 2 As a result, BCP significantly
Impact statement
Bone cancer pain (BCP) significantly decreases the life quality of patients or their life expectancy and causes a severe health burden to the society. However, as the exact mechanism of BCP is still poorly understood, no effective treatment has been developed yet. There are some pain medicines now, but they have some inevitable side effects. Additional therapeutic strategies are urgently needed. First, we revealed that preconditioning with H 2 S significantly reduced BCP, demonstrated by the decrease of thermal hyperalgesia and mechanical allodynia. Second, the mechanism of H 2 S preconditioning was elucidated. It may involve microglia deactivation and inflammation inhibition in the spinal cord, in which the proliferatoractivated receptor gamma/p38/Jun N-terminal kinase pathway is activated. This novel finding may significantly help us to understand the difference between the roles of endogenous H 2 S and exogenous H 2 S in the development of BCP and present us a new strategy of pain management.
decreases the life quality of patients or their life expectancy and causes a severe health burden to the society. 3 As the exact mechanism of BCP is still poorly understood, no effective treatment has been developed yet. There are some pain medicines now, but they have some inevitable side effects. Opiate pain relievers may induce constipation, drowsiness, dizziness, lightheadedness, or feeling faint, or even addiction when they are taken for more than a few days. Non-steroidal anti-inflammatory drugs, on the other hand, may cause stomach upset, heartburn, stomach ulcers, and kidney injury if used for a long duration. 4 As the complicated mechanism involved in BCP is still unclear, the development of pain management approaches is challenging, which makes additional therapeutic strategies urgently needed. 5 H 2 S has been recognized as a hazardous gas for a long time. Recent studies found that H 2 S could be synthesized via cystathionine beta-synthase (CBS) in mammalian tissues. It is involved in many physiological and pathological processes, including neurotransmission or inflammation. 6 Also, it has been reported that exogenous H 2 S may act as a neuroprotectant to protect against many central nervous system (CNS) diseases 7 by its antioxidation, antiinflammation, and antiapoptosis ability in models of many disorders in the CNS. [8] [9] [10] A recent study investigated the pain-relieving profile of some H 2 S donors, including natural allyl-isothiocyanate, synthetics phenyl-and carboxyphenyl-isothiocyanate in animal models of neuropathic pain. The results showed that single subcutaneous administrations of H 2 S donors and prototypical H 2 S donor NaHS reduced the hypersensitivity to cold non-noxious stimuli. The antineuropathic properties were abolished by the H 2 S-binding molecule hemoglobin, suggesting the antineuropathic role of H 2 S.
11 However, the effect of H 2 S preconditioning on neuropathic pain was seldom studied.
Some studies have implied that microglial activation and inflammatory cytokines in the nervous system might be essential in the regulation of neuropathic pain. 12, 13 Pottabathini et al. found out that peroxisome proliferatoractivated receptor gamma (PPARc) has got tremendous importance in nerve trauma and pain. 14 His results revealed that treatment with PPARc agonist pioglitazone significantly prevented the behavioral, biochemical, mitochondrial, and cellular alterations in spinal nerve ligated rats.
14 Multiple studies have shown the critical role of p38 mitogen-activated protein kinases (MAPK)/Jun N-terminal kinase (JNK) pathway in the neuropathic pain. Zhang et al. 15 suggested that activation of b2-adrenergic receptor in the spinal cord reduced neuropathic pain by reducing phosphorylation of microglial p38 MAPK and astrocytic JNK pathway.
Hence, in the present study, to study the antinociceptive effect of H 2 S in BCP, we first measured the changes of plasma H 2 S in patients with BCP and analyzed the relationship between them, then tested the hypothesis that pretreatment of H 2 S prevents BCP in rats. Hyperalgesia, allodynia, and inflammatory cytokines levels in the spinal cord were examined. The roles of PPARc, p38 MAPK, JNK, ERK, and microglia and astrocyte were also investigated to elucidate the underlying mechanism.
Materials and methods

Patient general information
A total of 45 patients with painful bone metastasis at Yunnan Tumor Hospital were included in this study, including 22 males and 23 females, aged from 43 to 60 years. They received patient's pain self-evaluation Visual Analogue Scales for three consecutive days and got the mean pain score, similarly to Cong et al. 16 All of them received standard treatment of pain. A total of 10 healthy individuals were recruited into Control group. The clinical trials were conducted according to Declaration of Helsinki principles, approved by the ethics committee of Yunnan Tumor Hospital. Inclusion criteria and Exclusion criteria are as same as the study of Cong et al.
16
Measurement of serum H 2 S levels Measurement of serum H 2 S levels was similar to the studies of Tian et al. 17 Venous blood (5 mL) was collected from patients at 10:00 each day for three consecutive days and centrifuged at 3000 r/min for 10 min. Standard sulfion and antioxidant solutions were prepared and a sulfur electrode in PXS-270 ion meter provided by Leici Company (Shanghai, China) was used to measure the H 2 S levels in the plasma. The electrode was activated in deionized water, then the ion meter was adjusted to mV; the rake ratio was adjusted to 100. The sulfur and reference electrodes were used to get reading and calculate the H 2 S concentration.
Animals and treatment
Adult male Wistar rats (230-250 g) were purchased from Yunnan Tumor Hospital experimental animal center and housed in the animal center of Yunnan Tumor Hospital. The room was lighted from 07:00 until 19:00. Rats were provided with food and water ad libitum. The whole experimental protocol was carried out under the guidelines of the International Association for the Study of Pain 18 and was approved by the Animal Care and Use Committee of Yunnan Tumor Hospital.
H 2 S inhalation
Similarly to Kida et al., 19 rats were put into a 30 L plastic chamber and allowed to breath air or air-H 2 S mixture at room pressure for seven days. Rats breathed H 2 S from 09:00 to 17:00 on each day. The H 2 S gas/air mixture continually flows through the chamber so the H 2 S concentration was maintained at 40 ppm. After the H 2 S inhalation, rats rested for 24 h prior to BCP procedure. Serum H 2 S levels in rats were measured immediately after the H 2 S inhalation with the method described above.
BCP procedure
Rats underwent BCP procedure according to the method of Mao-Ying et al. 20 Briefly, the mammary gland carcinoma cells were first prepared from Wistar rat. After rats were anaesthetized with ketamine (100 mg/kg, i.m.) and xylazine (7.5 mg/kg, i.m.), carcinoma cells (4 Â 10 5 ) or heat-killed carcinoma cells (sham group) were injected into the medullary cavity of tibia in 6 mL PBS with a 23-gauge needle. The wound was closed after the needle was removed 2 min later. Rats received i.m. injections of ampicillin and meloxicam for prophylaxis of postsurgical infection. All animals were allowed to three-day recovery before the following tests.
Assessment of thermal hyperalgesia and mechanical allodynia
The assessment of hyperalgesia and allodynia was similar to Yao et al. 21 For thermal hyperalgesia test, paw withdrawal latencies to a noxious thermal stimulus were recorded using a paw thermal stimulator (IITC Inc., Woodland Hills, CA, USA). Temperature was controlled at 30 C to make the baseline latency be 10-12 s. The average time to withdraw their paws from the thermal stimulus of rats was recorded as the "paw withdrawal latency" (repeated for three times). To prevent tissue damage, the maximum time was set at 20 s. For mechanical allodynia test, von Frey test was applied on the sciatic innervation surface of the hind paws. If rats respond positively to some filament for two times, the weight of the filament was recorded. The tests were carried out every other day to allow the rats to rest and keep a normal response to the stimulation. All the tests were performed by a professional investigator who was blind to the experimental design between 10:00 and 11:00.
Western blot analysis
The western blot analysis was similar to Hulse et al. 22 Briefly, rats were first terminally anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and perfused with cold saline solution. Afterward, the lumbar region of the spinal cord was collected and homogenized at 1000 g for 15 min. The proteins from supernatant were run on a SDS-PAGE gel (90 V, 1 h 30 min) and transferred to nitrocellulose membrane (100 V, 1 h). Membranes were then incubated with primary antibodies of p-PPARc, PPARc, p-p38, p38, p-ERK, ERK, p-JNK, JNK, Iba-1, GFAP, and b-actin overnight at 4 C. All primary antibodies were brought from Cell Signaling Technology (Danvers, MA, USA). After that, the membranes were washed and incubated with secondary antibody (1:2000; Santa Cruz, USA) at 25 C for 60 min. The band intensity was analyzed with the Quantity One software (Bio-Rad, Hercules, USA).
Evaluation of inflammatory cytokines (IL-1b, IL-6, and TNF-a)
The lumbar region of the spinal cord was collected after rats were sacrificed. After they were homogenized at 1500 g for 15 min, the supernatant was collected for inflammatory cytokines assays. The concentration of IL-1b, IL-6, and TNF-a was determined with commercial ELISA assays (DuoSet kits, R&D Systems, USA), following the instructions supplied by the manufacturer. The results are expressed as pg/mg protein.
Statistical analysis
All data are presented as the mean AE standard error of the mean. Pearson's correlation was used to detect and analyze the correlation between serum H 2 S levels and pain scores. Data in the animal experiments were analyzed by one-way analysis of variance followed by Bonferroni post hoc test using SPSS 17.0. The criterion for statistical significance was P <0.05.
Results
Correlation between serum H 2 S levels and pain scores
To establish the correlation between serum H 2 S levels and pain scores in BCP patients, we analyzed the results with Pearson's correlation. As shown in Figure 1 , the serum H 2 S level was negatively correlated with pain scores. When the serum H 2 S level gets higher, the pain score gets lower. The statistical analysis showed that the correlation is significant (y ¼ À0.102x þ 10, R 2 ¼ 0.590, r= À0.768, P < 0.0001). This result demonstrated that high levels of H 2 S in patients have low pain score, indicating a possible antinociceptive effect of H 2 S.
H 2 S preconditioning increased the serum H 2 S level in rats
The serum H 2 S level in rats was measured immediately after the H 2 S/air inhalation was done in four groups (n ¼ 10 for each group). As illustrated in Figure 2 , the normal serum H 2 S level in rats in the Sham and BCP rats was around 0.2 mM. Daily preconditioning with H 2 S for seven days increased the serum H 2 S level in rats to around 2.2 mM in BCP þ H 2 S and H 2 S groups (P < 0.05).
H 2 S preconditioning improved thermal hyperalgesia and mechanical allodynia induced by BCP As shown in Figure 3 , daily preconditioning with H 2 S for seven days reduced thermal hyperalgesia and mechanical allodynia induced by BCP procedure. There is a significant decrease in thermal withdrawal latency (Figure 3(a) ) and mechanical withdrawal threshold (Figure 3(c) ) in BCP group, which were prevented by H 2 S preconditioning The western blot analysis showed that BCP caused a slight increase in p-PPARc, p-p38, and p-JNK expression. When rats were treated with H 2 S preconditioning, they were further increased (Figure 4 (a) to (c)). BCP or H 2 S preconditioning caused no changes in p-ERK expression. When rats were treated with H 2 S preconditioning alone, the expression of p-PPARc, p-p38, p-JNK, or p-ERK was not significantly altered.
H 2 S preconditioning decreased the expression of inflammatory cytokines in spinal cord
To investigate the role of H 2 S preconditioning on inflammation, TNF-a, IL-1b, and IL-6 levels in the spinal cord were measured by ELISA. As shown in Figure 5 (a) to (c), BCP treatment sharply increased the inflammatory cytokines in the spinal cord, while H 2 S preconditioning significantly decreased them (P < 0.05). No significant change in the TNF-a, IL-1b, and IL-6 levels was found when rats were treated with H 2 S preconditioning alone.
H 2 S preconditioning attenuated the spinal microglia activation caused by BCP
As shown in Figure 6 (a), BCP increased the expression of Iba-1 (microglia marker) located in the ipsilateral dorsal horn, which was significantly reduced by H 2 S preconditioning (P < 0.05). Figure 6 (b) showed that GFAP (astrocyte marker) was not changed by BCP or H 2 S preconditioning. To explore the involvement of PPARc/p38/JNK pathway, we treated rats with PPARc inhibitor GW 9662, p38 inhibitor SB203580, and JNK inhibitor SP600125, then remeasured the effects of H 2 S preconditioning on thermal hyperalgesia and mechanical allodynia as well as microglia activation. The results showed that after rats were given GW 9662, SB203580, and SP600125, thermal hyperalgesia and mechanical allodynia were significantly decreased compared to the BCPþ H 2 S group (Figure 7(a) and (b) ). These inhibitors also increased microglia activation, as demonstrated by the increased expression of Iba-1( Figure  7 (c), P < 0.05). GW 9662, SB203580, and SP600125 alone did not affect the pain threshold (data not shown).
Inhibitors of PPARc/p38/JNK pathway abolished the effects of H 2 S preconditioning on inflammatory cytokines in spinal cord
To explore the role of PPARc/p38/JNK pathway on inflammatory cytokines, we treated rats with PPARc inhibitor GW 9662, p38 inhibitor SB203580, and JNK inhibitor SP600125, then remeasured the effects of H 2 S preconditioning on inflammatory cytokines. As shown in Figure 8 (a) to (c), after rats were given GW 9662, SB203580, and SP600125, the expression of TNF-a, IL-1b, and IL-6 in the spinal cord was increased compared to the BCPþ H 2 S group (P < 0.05).
Discussion
High concentration of H 2 S was considered a toxic gas which could inhibit complex IV in the electron transport chain. 23 In recent years, accumulating scientific evidence has shown that H 2 S is a third inorganic gaseous mediator (the other two are nitric oxide and carbon monoxide). Low concentration of H 2 S has protective effects on various injuries. 9, [24] [25] [26] [27] [28] For the first time, we demonstrated that in the BCP patients, the serum H 2 S level was negatively correlated with pain scores. The Pearson's statistical analysis showed that the correlation is significant (r= À0.768, p < 0.0001), indicating that H 2 S may be closely correlated with the pathology of BCP.
Preconditioning with H 2 S has raised special attention from scientists as it can evoke numerous downstream signaling pathways, such as Akt-GSK-3b signaling. 29, 30 However, the majority of the research subjects are ischemia/reperfusion injuries. The effect of H 2 S preconditioning on BCP has been less studied. The effect of H 2 S preconditioning on neuropathic pain has been less studied. Several studies have revealed the relationship between neuropathic pain and H 2 S (mostly endogenous H 2 S) and the results are controversial. Lin et al. 31 found out that NaHS, a H 2 S donor, alleviated chronic neuropathic pain by inhibiting expression of p-cAMP response element binding in the spinal cord. In another study, sensitization of purinergic P2X3 receptors was found to be mediated by CBS-H 2 S signaling in primary sensory neurons and contribute to discogenic pain. 32 Similarly, Terada and Kawabata 33 suggested that H 2 S appeared to facilitate the functions of anticalcium channel Cav3.2 and transient receptor potential cation channel A1. Also, endogenous CBS/H 2 S pathway was proven to promote the development of neuropathic pain. 34 To further study the mechanism of H 2 S involved in BCP, we preconditioned rats with H 2 S in an animal model of BCP. Our study confirmed that daily preconditioning with H 2 S for seven days increased the serum H 2 S level in rats from 0.2 mM to around 2.2 mM. H 2 S pretreatment significantly relieved neuropathic pain induced by BCP, as demonstrated by the decrease in thermal hyperalgesia and mechanical allodynia. As shown in Figure 3 , daily preconditioning with H 2 S for seven days prevented the development of thermal hyperalgesia and mechanical allodynia. The sharp decrease of thermal withdrawal latency and mechanical withdrawal threshold induced by BCP were prevented by H 2 S preconditioning.
Qu et al. 35 demonstrated that inhibitors of MAPKs could reduce mechanical allodynia and MAPKs-positive neurons in dorsal root ganglia play an important role in the mechanism. More particularly, the study of Zhou et al. 36 revealed that paeoniflorin and albiflorin could inhibit the p38 MAPK pathway and subsequently up-regulated proinflammatory cytokines (IL-1b and TNF-a). Similarly, PPARc prevents neuropathic pain development in rats, while blockade of PPARc with GW9662 reversed the inhibitory effect of pioglitazone on hypersensitivity. 37 In the present study, we found that BCP resulted in a slight increase in p-PPARc, p-p38, and p-JNK expression, which was further increased by H 2 S preconditioning. BCP treatment sharply increased the expression of TNF-a, IL-1b, and IL-6 in the spinal cord, which were significantly decreased by H 2 S preconditioning. These results suggest that H 2 S preconditioning may regulate the PPARc/p38/JNK pathway and inhibit the inflammatory response and BCP.
Microglias are immunocompetent cells in the CNS. They can quickly respond to injury and play an important role in maintaining tissue homeostasis. However, under abnormal conditions, including severe traumatic injury or inflammation in the CNS, microglia may secrete excess proinflammatory cytokines and reactive oxygen species, which exacerbate the neuronal damage. 38 Recently, microglia has emerged as a key player in eliciting neuropathic pain in the spinal cord. 10, 39 The fact that BCP increased Iba-1 (microglia marker) expression in the dorsal horn indicates the pivotal role of microglia in BCP development. The fact that H 2 S preconditioning decreased the Iba-1 expression suggests that the suppression of microglia proliferation by H 2 S preconditioning may be an important mechanism of the antinociceptive effects of H 2 S preconditioning.
To further confirm the involvement of PPARc/p38/JNK pathway, we treated rat with inhibitors of PPARc/p38/JNK pathway and then remeasured the thermal hyperalgesia and mechanical allodynia and microglia activation, as well as inflammatory cytokines. The results showed that PPARc inhibitor GW9662, p38 inhibitor SB203580, or JNK inhibitor SP600125 significantly decreased the thermal hyperalgesia and mechanical allodynia and microglia activation as well as inflammatory cytokines in spinal cord. These findings suggest that preconditioning with H 2 S may prevent neuropathic pain in rats through microglia deactivation and inflammation inhibition in the spinal cord, in which the PPARc/p38/JNK pathway is involved. This novel finding may significantly help us to understand the difference between the roles of endogenous H 2 S and exogenous H 2 S in BCP and present us a new strategy of pain management.
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